Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions

K L Couts1, E M Anderson, M M Gross

  • 1Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309-0215, USA.

Oncogene
|July 4, 2012
PubMed

Insights

Activating mutations in B-Raf signaling drive melanoma. This study reveals a network of microRNAs (miRNAs) controlled by this pathway, impacting cancer cell behavior and gene regulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Activating mutations in B-Raf, particularly B-RafV600E, are prevalent in melanomas.
  • These mutations lead to constitutive activation of the B-Raf/MKK/ERK signaling pathway, promoting cancer cell behavior.
  • The precise mechanisms by which B-RafV600E influences melanoma progression are not fully understood.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in melanoma pathogenesis driven by B-Raf mutations.
  • To identify miRNAs deregulated by the B-Raf/MKK/ERK pathway in melanoma cells.
  • To explore the functional interactions and regulatory roles of these miRNAs in cancer phenotypes.

Main Methods:

  • Utilized a microarray profiling platform to compare miRNA expression.
  • Analyzed miRNA expression in primary melanocytes versus B-RafV600E-positive melanoma cell lines.
  • Assessed the impact of an MKK1/2 inhibitor on miRNA expression in melanoma cells.

Main Results:

  • Identified a network of over 20 miRNAs deregulated by the B-Raf/MKK/ERK pathway in melanoma.
  • Found that these miRNAs modulate key cancer regulatory genes and functions, converging on protein regulation and cancer phenotypes.
  • Demonstrated that co-expressed miRNAs can augment protein repression and cell invasion, with observed latency and interference effects.

Conclusions:

  • The B-Raf/MKK/ERK pathway controls melanoma cell behavior and gene expression through the modulation of a miRNA network.
  • These miRNAs exhibit cross-regulatory functions and may act combinatorially to influence cancer phenotypes.
  • Highlights the potential for complex interactions within coordinately regulated miRNA networks in cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...